he company believes that current market conditions are not conducive for an offering on terms that would be in the best interests of its stockholders.
| |
| [28-November-2017] |
| LEAWOOD, Kan., Nov. 28, 2017 /PRNewswire/ -- Aratana Therapeutics (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it has terminated the offering of shares of its common stock that was announced on Monday, November 27, 2017. The company believes that current market conditions are not conducive for an offering on terms that would be in the best interests of its stockholders. Contacts For media inquiries:
View original content with multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-inc-announces-termination-of-offering-of-common-stock-300563255.html SOURCE Aratana Therapeutics, Inc. | ||
Company Codes: NASDAQ-NMS:PETX |
